We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-10.54%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$129B
AUM Growth
-$14.8B
Cap. Flow
+$5.69B
Cap. Flow %
4.39%
Top 10 Hldgs %
31.86%
Holding
7,834
New
489
Increased
2,471
Reduced
3,566
Closed
777

Sector Composition

Rank Sector Weight
1 Technology 6.9%
2 Healthcare 5.31%
3 Financials 5.25%
4 Communication Services 4.61%
5 Consumer Discretionary 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNG icon
5001
CALL
RingCentral
RNG
$5.3B
$91K ﹤0.01%
+1,100
New +$86.6K
TCX icon
5002
Tucows
TCX
$143M
$91K ﹤0.01%
1,511
-2,521
-63% -$141K
TEX icon
5003
CALL
Terex
TEX
$7.74B
$91K ﹤0.01%
3,300
-3,500
-51% -$112K
TMF icon
5004
CALL
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.14B
$91K ﹤0.01%
470
+460
+4,600% +$77.2K
UPLD icon
5005
Upland Software
UPLD
$14.2M
$91K ﹤0.01%
334
-659
-66% -$198K
VICR icon
5006
CALL
Vicor
VICR
$9.72B
$91K ﹤0.01%
2,400
+1,100
+85% +$40.2K
ANIP icon
5007
CALL
ANI Pharmaceuticals
ANIP
$1.71B
$90K ﹤0.01%
2,000
-200
-9% -$10.5K
EXR icon
5008
CALL
Extra Space Storage
EXR
$31B
$90K ﹤0.01%
+1,000
New +$90.9K
HOLX
5009
CALL
DELISTED
Hologic
HOLX
$90K ﹤0.01%
2,200
-21,900
-91% -$898K
IMMR icon
5010
PUT
Immersion
IMMR
$248M
$90K ﹤0.01%
10,100
+10,000
+10,000% +$93.5K
RYTM icon
5011
Rhythm Pharmaceuticals
RYTM
$7.77B
$90K ﹤0.01%
3,326
-3,301
-50% -$91.2K
INFN
5012
PUT
DELISTED
Infinera Corporation Common Stock
INFN
$90K ﹤0.01%
22,500
-5,800
-20% -$29.1K
ATRS
5013
DELISTED
Antares Pharma, Inc.
ATRS
$90K ﹤0.01%
33,164
-55,774
-63% -$184K
MXWL
5014
DELISTED
Maxwell Technologies Inc
MXWL
$90K ﹤0.01%
43,756
-101,502
-70% -$275K
HZNP
5015
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$90K ﹤0.01%
4,600
-1,600
-26% -$31.4K
ACA icon
5016
CALL
Arcosa
ACA
$7.12B
$89K ﹤0.01%
+3,201
New +$87.9K
BHF icon
5017
PUT
Brighthouse Financial
BHF
$3.38B
$89K ﹤0.01%
2,934
-1,080
-27% -$42.1K
CALX icon
5018
Calix
CALX
$2.49B
$89K ﹤0.01%
9,096
-42,641
-82% -$371K
CLH icon
5019
CALL
Clean Harbors
CLH
$16.4B
$89K ﹤0.01%
1,800
ENIC icon
5020
Enel Chile
ENIC
$6.18B
$89K ﹤0.01%
+18,057
New +$84.4K
PRGO icon
5021
PUT
Perrigo
PRGO
$1.78B
$89K ﹤0.01%
2,300
-95,400
-98% -$6.06M
VKTX icon
5022
Viking Therapeutics
VKTX
$3.94B
$89K ﹤0.01%
11,647
-137,082
-92% -$1.64M
ASNA
5023
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
$89K ﹤0.01%
1,770
+515
+41% +$36.4K
BBU
5024
DELISTED
Brookfield Business Partners
BBU
$88K ﹤0.01%
4,495
+1,379
+44% +$33.5K
DIN icon
5025
CALL
Dine Brands
DIN
$454M
$88K ﹤0.01%
1,300
-1,300
-50% -$108K

Similar funds

Barclays's Q4 2018 Portfolio in Review

As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.

  • Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
  • Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
  • Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
  • Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
  • Barclays opened 489 new positions and closed 777 in Q4 2018.
  • Barclays's portfolio value fell 10% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.